Canagliflozin-based Environmental Monitoring and Remediation Systems
Legal Citation
Summary of the Inventive Concept
The present inventive concept relates to novel applications of Canagliflozin in environmental monitoring and remediation, leveraging its glucose-sensing properties to detect and mitigate pollution in various industries.
Background and Problem Solved
The original patent disclosed a pharmaceutical composition comprising Canagliflozin for treating diabetes. However, the limitations of this patent lie in its restricted scope, failing to explore the broader potential of Canagliflozin in other fields. The present inventive concept addresses this limitation by applying Canagliflozin's glucose-sensing properties to environmental monitoring and remediation, providing a novel solution to the pressing issue of pollution.
Detailed Description of the Inventive Concept
The inventive concept comprises various systems and methods utilizing Canagliflozin-based sensors, catalysts, and enzymes to monitor and control environmental pollution. For instance, Claim 1 discloses a system for monitoring glucose levels in wastewater, enabling real-time detection of pollution. Claim 2 describes a method for reducing carbon footprint in industrial processes by enhancing glucose conversion efficiency using Canagliflozin-based catalysts. Similarly, Claim 3 presents a composition for bioremediation of contaminated soil, and Claim 4 describes a device for real-time monitoring of glucose levels in fermentation processes. Claim 5 outlines a process for producing biofuels using Canagliflozin-based enzymes.
Novelty and Inventive Step
The novelty of the present inventive concept lies in its application of Canagliflozin to environmental monitoring and remediation, which is entirely distinct from its original pharmaceutical application. The inventive step resides in the recognition of Canagliflozin's glucose-sensing properties and their adaptation to address pressing environmental concerns.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include using Canagliflozin-based sensors for monitoring glucose levels in air or soil, or developing Canagliflozin-based bioreactors for efficient glucose conversion. Variations could also involve combining Canagliflozin with other compounds to enhance its glucose-sensing properties or exploring its potential in other industries, such as food processing or agriculture.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in the environmental monitoring and remediation market, with potential applications in industries such as wastewater treatment, industrial processes, bioremediation, and biofuel production. The market size for environmental monitoring and remediation is projected to grow substantially in the coming years, driven by increasing concerns over pollution and climate change.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical chemistry, biotechnology, and environmental monitoring technologies involving glucose-related sensing and catalytic systems
Person of Ordinary Skill (PHOSITA) Profile
A skilled practitioner with expertise in pharmaceutical formulations, enzyme technologies, and environmental sensing systems, holding at least a master's degree in chemistry, biochemistry, or chemical engineering with 3-5 years of applied research experience
Obviousness Rationale
A PHOSITA would recognize that the unique glucose-sensing properties of Canagliflozin inherently suggest broader applications beyond pharmaceutical compositions. The molecular characteristics that enable glucose transport inhibition in pharmaceutical contexts naturally translate to sensing and catalytic technologies in environmental monitoring. The PTD's variations represent predictable extensions of the source patent's fundamental molecular understanding.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,559 |
|---|---|
| Title | Pharmaceutical composition comprising Canagliflozin, process of preparation and use thereof |
| Assignee(s) | Aurobindo Pharma Ltd |